U.S. Markets closed

Should You Expect CorVel Corporation (NASDAQ:CRVL) To Continue Delivering An ROE Of 21.68%?

Veer Mallick

CorVel Corporation (NASDAQ:CRVL) outperformed the Healthcare Services industry on the basis of its ROE – producing a higher 21.68% relative to the peer average of 13.68% over the past 12 months. Superficially, this looks great since we know that CRVL has generated big profits with little equity capital; however, ROE doesn’t tell us how much CRVL has borrowed in debt. In this article, we’ll closely examine some factors like financial leverage to evaluate the sustainability of CRVL’s ROE. See our latest analysis for CorVel

Peeling the layers of ROE – trisecting a company’s profitability

Return on Equity (ROE) weighs CorVel’s profit against the level of its shareholders’ equity. It essentially shows how much the company can generate in earnings given the amount of equity it has raised. In most cases, a higher ROE is preferred; however, there are many other factors we must consider prior to making any investment decisions.

Return on Equity = Net Profit ÷ Shareholders Equity

Returns are usually compared to costs to measure the efficiency of capital. CorVel’s cost of equity is 8.49%. Since CorVel’s return covers its cost in excess of 13.18%, its use of equity capital is efficient and likely to be sustainable. Simply put, CorVel pays less for its capital than what it generates in return. ROE can be broken down into three different ratios: net profit margin, asset turnover, and financial leverage. This is called the Dupont Formula:

Dupont Formula

ROE = profit margin × asset turnover × financial leverage

ROE = (annual net profit ÷ sales) × (sales ÷ assets) × (assets ÷ shareholders’ equity)

ROE = annual net profit ÷ shareholders’ equity

NasdaqGS:CRVL Last Perf Mar 23rd 18

Basically, profit margin measures how much of revenue trickles down into earnings which illustrates how efficient the business is with its cost management. Asset turnover reveals how much revenue can be generated from CorVel’s asset base. The most interesting ratio, and reflective of sustainability of its ROE, is financial leverage. Since ROE can be inflated by excessive debt, we need to examine CorVel’s debt-to-equity level. Currently, CorVel has no debt which means its returns are driven purely by equity capital. Therefore, the level of financial leverage has no impact on ROE, and the ratio is a representative measure of the efficiency of all its capital employed firm-wide.

NasdaqGS:CRVL Historical Debt Mar 23rd 18

Next Steps:

ROE is one of many ratios which meaningfully dissects financial statements, which illustrates the quality of a company. CorVel’s ROE is impressive relative to the industry average and also covers its cost of equity. ROE is not likely to be inflated by excessive debt funding, giving shareholders more conviction in the sustainability of high returns. ROE is a helpful signal, but it is definitely not sufficient on its own to make an investment decision.

For CorVel, I’ve put together three fundamental factors you should look at:

  1. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Valuation: What is CorVel worth today? Is the stock undervalued, even when its growth outlook is factored into its intrinsic value? The intrinsic value infographic in our free research report helps visualize whether CorVel is currently mispriced by the market.
  3. Other High-Growth Alternatives : Are there other high-growth stocks you could be holding instead of CorVel? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.